Volume 90 Issue 17 | p. 7 | News of The Week
Issue Date: April 23, 2012

GlaxoSmithKline Offers $2.6 Billion To Buy Human Genome Sciences

Department: Business
Keywords: pharmaceuticals, oncology, ovarian cancer

GlaxoSmithKline has made an unsolicited $2.6 billion bid for its long-standing partner Human Genome Sciences. The biotech firm has rejected the bid as too low and has hired Goldman Sachs and Credit Suisse to explore its options, including a sale to GSK or another firm.

GSK and HGS have been drug development and marketing partners since 1993, just two years after HGS was founded. To date, only one product . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society